Sika logo

Sika

Last updated February 10, 2026
80
Innovation Areas
3,042
Inventors
15
Collaborations

Inadequate mucosal drug bioavailability: SikaRecent Research Landscape

Topical and injectable formulations often cause localized tissue discomfort or inflammatory responses upon application. Reducing these adverse sensations improves patient compliance and safety.